BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Dako Incorporated

Identification of the origins of tumors and other diseases in body tissues has made great strides over the past two decades. As researchers expand their knowledge of cellular antigens and how these antigens are associated with various disorders, more accurate diagnoses can be made, leading to more effective patient treatments. Immunohistochemistry plays a key role in this process. It is this area in which DAKO is recognized as the world's leading supplier of reagents and staining systems.

DAKO continually expands its list of over 2000 monoclonal and polyclonal antibodies, complemented by a plethora of immunohistochemical staining kits, applicable for routine and advanced clinical and research use. With the introduction of an automated staining platform, DAKO is continually renewing its commitment to provide cost effective, comprehensive and time saving products to customers, to assist them in the most accurate testing and interpretation available.


Contact Details:
6392 Via Real
Carpinteria
CA
93013
United States of America
Tel:805-566-6655
Fax:805-566-1344
Email:
WWW:

www.dako.com/




Loading...

Recent Publications by Dako Incorporated:

The value of TOP2A gene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D.
BACKGROUND: Previous analyses of TOP2A and HER2 in the Danish Breast...
18th June, 2008
Dako A/S, Glostrup, Denmark. Acta Oncol. 2008;47(4):725-34.
DOI Direct Link
A simplified, sensitive immunohistochemical detection system employing signal amplification based on fluorescyl-tyramide/antifluorescein antibody reaction: its application to pathologic testing and research.
The catalyzed signal amplification (CSA) technique, based on the...
26th February, 2008
Department of Medical Science, Dako Japan, Inc, Kakkyoyama 18, Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):87-93.
DOI Direct Link
Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy.
Estrogen receptor (ER) and progesterone receptor (PR) status in breast...
8th November, 2007
Dako North America, Inc, Carpinteria, CA 93013, USA. Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):325-31.
DOI Direct Link
Improved fluorescent in situ hybridization method for detection of bacteria from activated sludge and river water by using DNA molecular beacons and flow cytometry.
Fluorescent in situ hybridization (FISH) remains a key technique in...
29th September, 2007
Dako UK Ltd., Denmark House, Angel Drove, Ely, Cambridgeshire CB7 4ET, Appl Environ Microbiol. 2007 Mar;73(6):2020-3. Epub 2007 Feb 2.
DOI Direct Link
Active caspase-3 and ultrastructural evidence of apoptosis in spontaneous and induced cell death in bovine in vitro produced pre-implantation embryos.
In this study we investigated chronological onset and involvement of...
29th August, 2007
Dako Denmark, Glostrup, Denmark. Mol Reprod Dev. 2007 Aug;74(8):961-71.
DOI Direct Link

View more Dako Incorporated research publications.

BioNews Results for Dako Incorporated:

Researchers find better way to distinguish melanoma from some benign moles
News-Medical.Net:  Jul 17 2008 10:31PM Matching: dako
As rates rise, researchers find better way to identify melanoma
Genetic Engineering News:  Jul 17 2008 4:09PM Matching: dako
Research and Markets: Latest Most Up-to-Date Cancer Personalized Medicine Market Report
TMC Net:  Jul 16 2008 12:51PM Matching: dako
Latest Most Up-to-Date Cancer Personalized Medicine Market Report
SmartBrief:  Jul 16 2008 9:01AM Matching: dako
Latest Most Up-to-Date Cancer Personalized Medicine Market Report
Houston Chronicle:  Jul 16 2008 8:31AM Matching: dako
Promote your company here: BioNewsCast - Press Release Distribution

View more Dako Incorporated news.

Dako Incorporated Patents:

US Patent No.Title
7368245 Method and probes for the detection of chromosome aberrations
6310179 2-or 3-dimensional geometric structures
6287772 Methods, kits and compositions for detecting and quantitating target sequences
6235476 Process for detecting nucleic acids by mass determination
6169169 PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis

View more Dako Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 326 times since April 2007, the link to the organisation's website has been followed 67 times

Recent Search Terms used to find this page: dako company in carpinteria | caspase 3 dAKO | 805-566-1344 | fluorescyl Tyramide for FISH | dako incorporated | dako incorporated | Appl Immunohistochem Mol Morphol. 2007 Sep153325-31 | director at dako.com | .

Search for more companies in Carpinteria

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Dako Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.